Benjamin Morgan Scirica MD
Cardiologist and Director, Innovation, Cardiovascular Division, Brigham and Women's Hospital; Associate Professor of Medicine, Harvard Medical School; Senior Investigator, TIMI Study Group, Boston, MassachusettsDr. Benjamin Scirica graduated from Harvard Medical School and trained in internal medicine and cardiovascular medicine at Brigham and Women's Hospital in Boston, Massachusetts. He has a MPH health degree from Harvard School of Public Health. He is currently a Senior Investigator at the TIMI Study Group (an academic research organization based at Brigham and Women's Hospital that has performed over 70 clinical trials in atherosclerotic heart disease), an attending cardiologist and Director of Innovation at the cardiovascular division at Brigham and Women's Hospital, and an associate professor of medicine at Harvard Medical School.
His research interests center on the risk stratification, management, and CV risk reduction of patients with acute coronary syndromes and cardiometabolic disorders. He is the Director of the TIMI ECG Core Laboratory, which has analyzed over 20,000 continuous and static ECGs from multiple trials in acute coronary syndromes, including the ExTRACT-TIMI 25, CLARITY-TIMI 28, DISPERSE-2, PLATO, and MERLIN-TIMI 36 trials. He was principal investigator or co-investigator of the MERLIN-TIMI 36, AVANT GARDE-TIMI 43, TRA 2Pº-TIMI 50, SAVOR-TIMI 53, and CAMELLIA-TIMI 58 trials.
Dr. Scirica has authored or co-authored over 150 peer-reviewed articles, serves on the editorial board of ACCEL, and is a reviewer for multiple journals, including New England Journal, JAMA, The Lancet, Circulation, and Journal of the American College of Cardiology (JACC). He attend in the cardiac intensive care unit at Brigham and Women’s Hospital.
Positions:
Attending Cardiologist and Director, Innovation, Cardiovascular Division, Brigham and Women's Hospital; Associate Professor of Medicine, Harvard Medical School; Senior Investigator, TIMI Study Group, Boston, Massachusetts
Degrees:
MD: Harvard Medical School
MPH: Harvard School of Public Health
Postgraduate Training:
Fellowship (internal medicine and cardiovascular medicine): Brigham and Women's Hospital, Boston, Massachusetts
Research Interests:
Identification and application of novel cardiac biomarkers and electrocardiographic techniques
Disclosures
Dr. Scirica reports institutional research grants to Brigham and Women’s Hospital from AstraZeneca, Eisai, Merck, Novartis, NovoNordisk, and Pfizer. Consulting fees from AbbVie, Allergan, AstraZeneca, Boehringer Ingelheim, Eisai, Elsevier Practice Update Cardiology, Esperion, Hamni, Lexicon, Medtronic, Merck, NovoNordisk, and equity in Health [at] Scale.
Recent Contributions to PracticeUpdate:
- Adverse Cardiac Events in Patients With Chest Pain at Hospital Admission
- Neuron-Specific Enolase Is a Robust Predictor of Poor Neurological Outcome After Out-of-Hospital Cardiac Arrest
- Risk for Gastrointestinal Bleeding With Dabigatran, Rivaroxaban, and Warfarin
- Risk for Gastrointestinal Bleeding Associated With Oral Anticoagulants
- Recognition of Incident Diabetes During an Acute MI
- Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis
- Clinical Picture and Risk for Short-Term Mortality in Cardiogenic Shock
- Cardiac Screening With Electrocardiography, Stress Echocardiography, or Myocardial Perfusion Imaging
- Heart Failure in Patients With Type 2 Diabetes Taking Alogliptin
- ACC.15: SCOT-HEART–Coronary CTA and Nailing the Diagnosis of Coronary Heart Disease